Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-30 · accession 0001209191-21-044516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | 2021-06-30 | CRSP | Novak Rodger | Pres, Dir | S - Sale | $165.00 | -25.0K | 573.0K | -4% | -$4.12M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-06-30 | S | D | 25,000 | $165.00 | 573,007 | D | — | — |